← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2008Last known activity
May 31, 2020
Defunct as of Dec 31, 2025
Timeline
2000s
- Jun 1, 2001
Humanigen— Founded
2020s
- Dec 31, 2025
Humanigen— Defunct
Drugs by trial phase (7 distinct, 10 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Indications
Studied for
- Arthritis
- Arthritis, Rheumatoid
- Asthma
- Coronavirus Infections
- Cystic Fibrosis
- Fibrosis
- Glioblastoma
- Leukemia
- Leukemia, Myelomonocytic, Acute
- Leukemia, Myelomonocytic, Chronic
- Leukemia, Myelomonocytic, Juvenile
- Lymphoma
- Lymphoma, B-Cell
- Myelodysplastic Syndromes
- Neoplasms
- Pneumonia
- Pneumonia, Ventilator-Associated
- Preleukemia
- Primary Myelofibrosis
- Pseudomonas Infections
- Syndrome
Recent trials (16)
- NCT04351152Lead sponsorPhase 3May 31, 2020
- NCT04351152Study directorPhase 3May 31, 2020
- NCT04314843CollaboratorPhase 1/Phase 2Apr 30, 2020
- NCT03374943CollaboratorPhase 1Dec 5, 2017
- NCT02546284Lead sponsorPhase 1Jul 1, 2016
- NCT01695343Lead sponsorPhase 2Dec 1, 2012
- NCT01695343Study chairPhase 2Dec 1, 2012
- NCT01603277Lead sponsorPhase 2Jul 1, 2012
- NCT01603277Study chairPhase 2Jul 1, 2012
- NCT01211691Study directorPhase 1/Phase 2Sep 1, 2010
- NCT01211691Lead sponsorPhase 1/Phase 2Sep 1, 2010
- NCT00995449Study chairPhase 2Jan 1, 2010
- NCT00995449Lead sponsorPhase 2Jan 1, 2010
- NCT00691587Lead sponsorPhase 1/Phase 2Apr 1, 2008
- NCT00638365Study directorPhase 1/Phase 2Mar 1, 2008
Details
- Founded
- Brisbane, CA, US Jun 1, 2001
- Last known activity
- May 31, 2020